Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Program"

被引：2
|
作者：
Hess, Paul L.
Hernandez, Adrian F.
Bhatt, Deepak L.
Hellkamp, Anne S.
Yancy, Clyde W.
Schwamm, Lee H.
Peterson, Eric D.
Schulte, Phillip J.
Fonarow, Gregg C.
Al-Khatib, Sana M.
机构：
来源：
CIRCULATION | 2017年 / 135卷 / 03期
关键词：
PRIMARY PREVENTION;
D O I：
10.1161/CIRCULATIONAHA.116.025791
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：E22 / E23
页数：2
相关论文
共 38 条
  • [31] Letter by Littmann Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry"
    Littmann, Laszlo
    CIRCULATION, 2020, 141 (11) : E646 - E647
  • [32] Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"
    Figtree, Gemma A.
    Radholm, Karin
    Neal, Bruce
    CIRCULATION, 2019, 139 (03) : 418 - 419
  • [33] Response by Bergmark et al to Letter Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial"
    Bergmark, Brian A.
    Bhatt, Deepak L.
    McGuire, Darren K.
    Scirica, Benjamin M.
    CIRCULATION, 2020, 141 (04) : E57 - E58
  • [34] Response by Tseng et al to Letter Regarding Article, "Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis"
    Tseng, Andrew S.
    Kunze, Katie L.
    Mulpuru, Siva K.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2019, 12 (08):
  • [35] Letter regarding article by masoudi et al, "National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction" - Response
    Masoudi, FA
    Havranek, EP
    Rathore, SS
    Wang, YF
    Curtis, JP
    Foody, JM
    Krumholz, HM
    CIRCULATION, 2005, 111 (17) : E276 - E277
  • [36] Letter by Mordi et al Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial"
    Mordi, Ify R.
    Mohan, Mohapradeep
    Lang, Chim C.
    CIRCULATION, 2020, 141 (04) : E55 - E56
  • [37] Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial"
    Lopes, Renato D.
    Alexander, Karen P.
    Hochman, Judith S.
    Maron, David J.
    CIRCULATION, 2021, 143 (20) : e961 - e962
  • [38] Response by Di Biase et al to Letter Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial"
    Di Biase, Luigi
    Mohanty, Prasant
    Mohanty, Sanghamitra
    Santangeli, Pasquale
    Trivedi, Chintan
    Lakkireddy, Dhanunjaya
    Reddy, Madhu
    Jais, Pierre
    Themistoclakis, Sakis
    Dello Russo, Antonio
    Casella, Michela
    Pelargonio, Gemma
    Narducci, Maria Lucia
    Schweikert, Robert
    Neuzil, Petr
    Sanchez, Javier
    Horton, Rodney
    Beheiry, Salwa
    Hongo, Richard
    Hao, Steven
    Rossillo, Antonio
    Forleo, Giovanni
    Tondo, Claudio
    Burkhardt, J. David
    Haissaguerre, Michel
    Natale, Andrea
    CIRCULATION, 2016, 134 (10) : E189 - E190
1234